YONGIN, South Korea , Feb. 11, 2025 /PRNewswire/ — GC Biopharma, a South Korean biopharmaceutical company, announced on Feb. 10th that it presented development updates on its LSD (lysosomal storage disorder) pipelines at the WORLD Symposium 2025, […]
YONGIN, South Korea, Nov. 25, 2024 /PRNewswire/ — GC Biopharma and Novel Pharma today announced that the first patient in the US has been dosed in multinational clinical trial with ‘GC1130A’, an innovative new drug […]
YONGIN, South Korea, Oct. 28, 2024 /PRNewswire/ — GC Biopharma announced that it has signed an agreement with Novelty Nobility, a biotech company specializing in the development of antibody-based therapeutics, for the joint research and […]
